CXCR2 as a Novel Target for Overcoming Resistance to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Cell

2021 ◽  
Author(s):  
Ji-Hea Kim ◽  
Seung-Jin Lee ◽  
Ka Won Kang ◽  
Byung-Hyun Lee ◽  
Yong Park ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Kinase Inhibitors ◽  
Leukemia Cell ◽  
Myelogenous Leukemia ◽  
Chronic Myelogenous Leukemia Cell ◽  
Novel Target

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees

2020 ◽  
pp. 1-15
Author(s):  
Eric J. Chow ◽  
David R. Doody ◽  
Jennifer J. Wilkes ◽  
Laura K. Becker ◽  
Shasank Chennupati ◽  
...  
Keyword(s):  
Adverse Events ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Health Plan ◽  
Real World ◽  
Kinase Inhibitors ◽  
Myelogenous Leukemia

scholarly journals Blast Phase in Chronic Myelogenous Leukemia Is Skewed Toward Unusual Blast Types in Patients Treated With Tyrosine Kinase Inhibitors

2015 ◽  
Vol 143 (1) ◽  
pp. 105-119 ◽  
Author(s):  
Yang Shi ◽  
Andrew J. Rand ◽  
Jennifer H. Crow ◽  
Joseph O. Moore ◽  
Anand S. Lagoo
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Kinase Inhibitors ◽  
Myelogenous Leukemia ◽  
Blast Phase

Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors

2015 ◽  
Vol 102 (3) ◽  
pp. 342-348 ◽  
Author(s):  
Masatoshi Sakurai ◽  
Takehiko Mori ◽  
Daiki Karigane ◽  
Keiichi Tozawa ◽  
Eri Matsuki ◽  
...  
Keyword(s):  
Young Adults ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Kinase Inhibitors ◽  
Unfavorable Outcome ◽  
Myelogenous Leukemia ◽  
Adolescent And Young Adults

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study

2018 ◽  
Vol 67 ◽  
pp. 41-48 ◽  
Author(s):  
Maël Heiblig ◽  
Delphine Rea ◽  
Marie-Lorraine Chrétien ◽  
Aude Charbonnier ◽  
Philippe Rousselot ◽  
...  
Keyword(s):  
Observational Study ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Kinase Inhibitors ◽  
Real Life ◽  
Myelogenous Leukemia

scholarly journals Population-based utilization and costs associated with tyrosine kinase inhibitors for first-line treatment of chronic myelogenous leukemia among elderly patients

2020 ◽  
Vol 26 (12) ◽  
pp. 1494-1504
Author(s):  
Donna R Rivera ◽  
Lindsey Enewold ◽  
Michael J Barrett ◽  
Matthew P Banegas ◽  
Kelly K Filipski ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Chronic Myelogenous Leukemia ◽  
Kinase Inhibitors ◽  
Population Based ◽  
Myelogenous Leukemia ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document